Chapter 2 Managing Tumor Angiogenesis. Lessons from VEGF-Resistant Tumors and Wounds

Ileana Cuevas, Nancy Boudreau

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

It is now well established both experimentally and clinically, that new blood vessel growth is required for tumors to grow beyond a few millimeters and metastasize [Folkman, J. (1995). In: Mendelsohn, L., Howley, P., Israel, A. (Eds.), The Molecular Basis of Cancer, WB Saunders Company, Philadelphia, pp. 206-225]. Angiogenesis, the process of forming new blood vessels from preexisting vessels, provides the tumor with additional oxygen and nutrients for its continued growth. In addition, the proximity and increase in vascular density enhance the likelihood of tumor cells entering the bloodstream to eventually metastasize. Since the initial observations of Dr. Folkman in the late 1970s, research over the past 30 years has focused intensely on identifying points in which the angiogenic cycle can be disrupted and has become an important component of current therapies to limit tumor progression.

Original languageEnglish (US)
Pages (from-to)25-42
Number of pages18
JournalAdvances in Cancer Research
Volume103
Issue numberC
DOIs
StatePublished - 2009

Fingerprint

Vascular Endothelial Growth Factor A
Wounds and Injuries
Blood Vessels
Neoplasms
Israel
Growth
Oxygen
Food
Research
Therapeutics

Keywords

  • BMDC
  • bone marrow-derived cells
  • EC
  • endothelial cell
  • endothelial progenitor cell
  • EPC
  • HIF
  • hypoxia inducible factor
  • matrix metalloproteinase
  • MMP
  • MMTV
  • mouse mammary tumor virus
  • vascular endothelial growth factor
  • VEGF
  • VEGF receptor
  • VEGFR

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Chapter 2 Managing Tumor Angiogenesis. Lessons from VEGF-Resistant Tumors and Wounds. / Cuevas, Ileana; Boudreau, Nancy.

In: Advances in Cancer Research, Vol. 103, No. C, 2009, p. 25-42.

Research output: Contribution to journalArticle

Cuevas, Ileana ; Boudreau, Nancy. / Chapter 2 Managing Tumor Angiogenesis. Lessons from VEGF-Resistant Tumors and Wounds. In: Advances in Cancer Research. 2009 ; Vol. 103, No. C. pp. 25-42.
@article{8f71816a6da64735b3238b9a19d6bf2b,
title = "Chapter 2 Managing Tumor Angiogenesis. Lessons from VEGF-Resistant Tumors and Wounds",
abstract = "It is now well established both experimentally and clinically, that new blood vessel growth is required for tumors to grow beyond a few millimeters and metastasize [Folkman, J. (1995). In: Mendelsohn, L., Howley, P., Israel, A. (Eds.), The Molecular Basis of Cancer, WB Saunders Company, Philadelphia, pp. 206-225]. Angiogenesis, the process of forming new blood vessels from preexisting vessels, provides the tumor with additional oxygen and nutrients for its continued growth. In addition, the proximity and increase in vascular density enhance the likelihood of tumor cells entering the bloodstream to eventually metastasize. Since the initial observations of Dr. Folkman in the late 1970s, research over the past 30 years has focused intensely on identifying points in which the angiogenic cycle can be disrupted and has become an important component of current therapies to limit tumor progression.",
keywords = "BMDC, bone marrow-derived cells, EC, endothelial cell, endothelial progenitor cell, EPC, HIF, hypoxia inducible factor, matrix metalloproteinase, MMP, MMTV, mouse mammary tumor virus, vascular endothelial growth factor, VEGF, VEGF receptor, VEGFR",
author = "Ileana Cuevas and Nancy Boudreau",
year = "2009",
doi = "10.1016/S0065-230X(09)03002-4",
language = "English (US)",
volume = "103",
pages = "25--42",
journal = "Advances in Cancer Research",
issn = "0065-230X",
publisher = "Academic Press Inc.",
number = "C",

}

TY - JOUR

T1 - Chapter 2 Managing Tumor Angiogenesis. Lessons from VEGF-Resistant Tumors and Wounds

AU - Cuevas, Ileana

AU - Boudreau, Nancy

PY - 2009

Y1 - 2009

N2 - It is now well established both experimentally and clinically, that new blood vessel growth is required for tumors to grow beyond a few millimeters and metastasize [Folkman, J. (1995). In: Mendelsohn, L., Howley, P., Israel, A. (Eds.), The Molecular Basis of Cancer, WB Saunders Company, Philadelphia, pp. 206-225]. Angiogenesis, the process of forming new blood vessels from preexisting vessels, provides the tumor with additional oxygen and nutrients for its continued growth. In addition, the proximity and increase in vascular density enhance the likelihood of tumor cells entering the bloodstream to eventually metastasize. Since the initial observations of Dr. Folkman in the late 1970s, research over the past 30 years has focused intensely on identifying points in which the angiogenic cycle can be disrupted and has become an important component of current therapies to limit tumor progression.

AB - It is now well established both experimentally and clinically, that new blood vessel growth is required for tumors to grow beyond a few millimeters and metastasize [Folkman, J. (1995). In: Mendelsohn, L., Howley, P., Israel, A. (Eds.), The Molecular Basis of Cancer, WB Saunders Company, Philadelphia, pp. 206-225]. Angiogenesis, the process of forming new blood vessels from preexisting vessels, provides the tumor with additional oxygen and nutrients for its continued growth. In addition, the proximity and increase in vascular density enhance the likelihood of tumor cells entering the bloodstream to eventually metastasize. Since the initial observations of Dr. Folkman in the late 1970s, research over the past 30 years has focused intensely on identifying points in which the angiogenic cycle can be disrupted and has become an important component of current therapies to limit tumor progression.

KW - BMDC

KW - bone marrow-derived cells

KW - EC

KW - endothelial cell

KW - endothelial progenitor cell

KW - EPC

KW - HIF

KW - hypoxia inducible factor

KW - matrix metalloproteinase

KW - MMP

KW - MMTV

KW - mouse mammary tumor virus

KW - vascular endothelial growth factor

KW - VEGF

KW - VEGF receptor

KW - VEGFR

UR - http://www.scopus.com/inward/record.url?scp=71149092898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=71149092898&partnerID=8YFLogxK

U2 - 10.1016/S0065-230X(09)03002-4

DO - 10.1016/S0065-230X(09)03002-4

M3 - Article

C2 - 19854351

AN - SCOPUS:71149092898

VL - 103

SP - 25

EP - 42

JO - Advances in Cancer Research

JF - Advances in Cancer Research

SN - 0065-230X

IS - C

ER -